855 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Tuesday’s Close
TEVA Teva Pharmaceutical Industries Limited $23.43 $23.86B N/A
Article Searches
Allergan's Dermal Filler for Wrinkle Correction Gets FDA Nod http://www.zacks.com/stock/news/253593/allergans-dermal-filler-for-wrinkle-correction-gets-fda-nod?cid=CS-ZC-FT-253593 Mar 21, 2017 - Allergan plc (AGN) announced yesterday that the FDA has approved its Juvederm Vollure XC dermal filler for correction of facial wrinkles and folds in adults over the age of 21.
Nektar's Pain Drug Positive in Phase III Study; Shares Gain http://www.zacks.com/stock/news/253567/nektars-pain-drug-positive-in-phase-iii-study-shares-gain?cid=CS-ZC-FT-253567 Mar 21, 2017 - Nektar Therapeutics??? (NKTR) shares surged 42.6% after the company announced positive results from a phase III efficacy study evaluating its investigational candidate, NKTR-181, in patients with moderate to severe chronic low back pain.
AstraZeneca (AZN) Gets Another CRL for ZS-9; Inks COPD Deal http://www.zacks.com/stock/news/253385/astrazeneca-azn-gets-another-crl-for-zs-9-inks-copd-deal?cid=CS-ZC-FT-253385 Mar 20, 2017 - London based AstraZeneca plc (AZN) received a second Complete Response Letter (CRL) from the FDA for its new drug application (NDA) for investigational drug ZS-9.
Teva Launches Authorized Generic of Allergan's Minastrin http://www.zacks.com/stock/news/253207/teva-launches-authorized-generic-of-allergans-minastrin?cid=CS-ZC-FT-253207 Mar 17, 2017 - Teva Pharmaceutical Industries Ltd. (TEVA) recently launched an authorized generic version of Allergan plc???s (AGN) oral contraceptive, Minastrin 24 Fe1, in the U.S.
Teva's Chorea Approval And Osteoporosis Data For Amgen http://seekingalpha.com/article/4054231-tevas-chorea-approval-osteoporosis-data-amgen?source=feed_sector_healthcare Mar 10, 2017 - Welcome to your weekly digest of approaching regulatory and clinical readouts. Teva (NYSE:TEVA) expects a US decision on SD-809, its possible treatment for Huntington’s chorea, at the beginning of Apr
Teva-Takeda Japanese Joint Venture Adds $450M Revenue For Q4 http://seekingalpha.com/article/4046364-teva-takeda-japanese-joint-venture-adds-450m-revenue-q4?source=feed_tag_israel Feb 15, 2017 - Teva's joint venture with long-time Japanese OTC drug company Takeda began during 2016.The joint venture added $450M in generics revenue during the 4th Quarter of 2016.TEVA looks set to continue growi
Teva Pharmaceuticals Has Bottomed This Time http://seekingalpha.com/article/4046306-teva-pharmaceuticals-bottomed-time?source=feed_tag_israel Feb 15, 2017 - Teva's management fielded calls that put its dividend into question. Suggestions that company should split signals the stock's undervaluation. Teva's growth ahead in generics and specialty overlooked:
Markets Climb Amid Solid Q4 Earnings http://www.zacks.com/stock/news/249222/markets-climb-amid-solid-q4-earnings?cid=CS-ZC-FT-249222 Feb 13, 2017 - Market futures are very positive this morning, and continue to climb 20 minutes before the opening bell sounds.
Teva's New Approach http://seekingalpha.com/article/3996426-tevas-new-approach?source=feed_tag_israel Aug 05, 2016 - Earlier last week, the Federal Trade Commission approved of Teva's acquisition of Allergan's generic pharma unit.Unsurprisingly, the +$40 Billion deal was closed this week.Teva's aggressive growth str
Stock Market News for August 05, 2016 http://www.zacks.com/stock/news/227074/stock-market-news-for-august-05-2016?cid=CS-ZC-FT-227074 Aug 05, 2016 - Benchmarks ended mostly flat on Thursday as investors refrained from making big bets ahead of Friday’s U.S. nonfarm payroll report

Pages: 1...7677787980818283848586

<<<Page 81>